CompletedInterventionalPhase 2Updated Nov 11, 2010
Study in Patients With COPD | NCT00215423 | Trialant
CompletedInterventionalPhase 2Updated Nov 11, 2010
Study in Patients With COPD
ClinicalTrials.gov ID
NCT00215423
Lead Sponsor
DeyINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 2
Enrollment
49
Last Update Posted
Nov 11, 2010Estimated
Primary Completion Date
Dec 2003Actual
Completion Date
Sep 2005Actual
Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug